1 / 9

Comprehensive Overview of ABRIFAR: Leading Pharmaceutical Distributors in Brazil

The Brazilian Association of Distributors and Importers of Pharmaceuticals Raw Materials (ABRIFAR) represents 31 companies responsible for 95% of Brazil's API and excipient imports. ABRIFAR ensures compliance with ANVISA regulations, providing pathways for qualification of API suppliers and a rigorous documentation process. Their role is vital for local pharmaceutical industries and manipulation pharmacies. ABRIFAR guides partners through certification, registration, and qualification, ensuring adherence to national standards while addressing the complexities of API registration and stability requirements in Brazil.

kaelem
Télécharger la présentation

Comprehensive Overview of ABRIFAR: Leading Pharmaceutical Distributors in Brazil

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Brazilian Association of Distributors and Importers of Pharmaceuticals Raw Materials. www.abrifar.org.br São Paulo 2011

  2. ABRIFAR Afiliates • 31 Companies; • - 95% of the total imports of API/Excipients that are distributed to local companies; • - Clients: Industries and manipulation pharmacies.

  3. Supplying API to Brazil • With ANVISA • Without ANVISA Generic Similar Suppliers qualification with individual criteria Qualification DMF RDC 249 RDC 204 RDC 17 API

  4. ANVISA Resolution 57/09 Manufacturers / Importers Diploma API Register International Plant Inspection Certification

  5. Model of API Registration ANVISA Resolution 57/09 API Registration Suppliers qualification Approval / Certification of the Plant DMF/AMD International Plant Inspection Presentation of Documents and Payment R$ 37.000,00 (around US$ 20.000)

  6. New Commercial Model After ANVISA Resolution 57/09 Finished Dosage Forms API API New model Registration of Medicine Reduction of the level of freedom for changing suppliers X High Production Costs Suppliers “Plant Inspection” Certificate ANVISA Selection Qualification Biostudies API Registration Stability

  7. Brazilian Particularities Registration belongs to the Brazilian Company – (AFE); R$ 37.000,00: API/Plant - Every 12 months; PS: Intermediates “X” are the possibilities of API registration numbers.

  8. Reliable partnerships In the Past: “Price only” API supplier selection • Company documents • API documents • Supplier qualification • ANVISA inspection • Price of API

  9. Thank you for your attention! www.abrifar.org.br abrifar@abrifar.org.br For technical questions: fabiana@abrifar.org.br Rua Afonso Celso, 1221- Cj. 61 – São Paulo/SP – Brasil Phone: +55 11 5071 1681 Fax: +55 11 2578 1047

More Related